Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question

Lignende værker

• Diagnosis of pseudoprogression using MRI perfusion in patients with glioblastoma multiforme may predict improved survival
  af: Gahramanov, Seymur, et al.
  Udgivet: (2014)
• Pseudoprogression of Glioblastoma after Chemo- and Radiation Therapy: Diagnosis by Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging with Ferumoxytol versus Gadoteridol and Correlation with Survival
  af: Gahramanov, Seymur, et al.
  Udgivet: (2013)
• P17.62 THE IMPORTANCE OF DELAYED PSEUDOPROGRESSION AND THE PROBLEM WITH RANO IN GBM
  af: Neuwelt, E.A., et al.
  Udgivet: (2014)
• Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab
  af: Netto, Joao Prola, et al.
  Udgivet: (2016)
• Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol versus gadoteridol: A pilot study
  af: Gahramanov, Seymur, et al.
  Udgivet: (2010)